Terms: = Gastric cancer AND LCP1, CP64, 3936, ENSG00000136167, FLJ39956, DKFZp781A23186, L-PLASTIN, FLJ25423, P13796, FLJ26114, PLS2, LC64P
8 results:
1. Comparison of the effects of perioperative and adjuvant chemotherapy on outcomes of operable gastric cancer: A retrospective cohort experience from a tertiary cancer center.
Ali J; Humayun N; Ikram S; Bakar MA; ; Sheikh RM
J Pak Med Assoc; 2023 Apr; 73(4):812-815. PubMed ID: 37051990
[TBL] [Abstract] [Full Text] [Related]
2. Exploring a shared genetic signature and immune infiltration between spontaneous intracerebral hemorrhage and Helicobacter pylori infection.
Liu X; Li M; Han Q; Zuo Z; Wang Q; Su D; Fan M; Chen T
Microb Pathog; 2023 May; 178():106067. PubMed ID: 36914055
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptome Profiling Analysis Identifies lcp1 as a Contributor for Chidamide Resistance in gastric cancer.
Bao W; Zhu Z; Gao Y; Chen J
Pharm Res; 2022 May; 39(5):867-876. PubMed ID: 35578065
[TBL] [Abstract] [Full Text] [Related]
4. l-plastin Promotes gastric cancer Growth and Metastasis in a
Teng YS; Chen WY; Yan ZB; Lv YP; Liu YG; Mao FY; Zhao YL; Peng LS; Cheng P; Duan MB; Chen W; Wang Y; Luo P; Zou QM; Chen J; Zhuang Y
Mol Cancer Res; 2021 Jun; 19(6):968-978. PubMed ID: 33771880
[TBL] [Abstract] [Full Text] [Related]
5. lcp1 is a prognostic biomarker correlated with immune infiltrates in gastric cancer.
Zeng Q; Li L; Feng Z; Luo L; Xiong J; Jie Z; Cao Y; Li Z
Cancer Biomark; 2021; 30(1):105-125. PubMed ID: 32986657
[TBL] [Abstract] [Full Text] [Related]
6. Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer.
Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
Korean J Intern Med; 2006 Mar; 21(1):20-7. PubMed ID: 16646560
[TBL] [Abstract] [Full Text] [Related]
7. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract] [Full Text] [Related]
8. cancer risk at sites other than the breast following augmentation mammoplasty.
Brinton LA; Lubin JH; Burich MC; Colton T; Brown SL; Hoover RN
Ann Epidemiol; 2001 May; 11(4):248-56. PubMed ID: 11306343
[TBL] [Abstract] [Full Text] [Related]
